基于牛津分型的新型评分系统提示IgA肾病激素治疗的应用
本研究基于858例IgA肾病患者,评估激素治疗对长期预后及不同MEST-C评分的影响,构建激素应答评分(SRS)与激素无应答评分(SNRS)。匹配后激素治疗改善20年肾脏生存率(75.5% vs 61.7%,P=0.025),M1、E1、S1、C1+2评分患者应答,T1+2评分患者不应答。
要点
- 激素治疗改善IgA肾病患者匹配后20年肾脏生存率(75.5% vs 61.7%,P=0.025)。
- M1、E1、S1、C1+2评分患者对激素治疗有应答,T1+2评分患者无应答。
- 高SRS是激素治疗的有效指标,SNRS提示激素抵抗。
核心结论
- M1、E1、S1和C1+2评分患者对激素治疗有应答,而T1+2评分患者无应答;高SRS是激素治疗的有效指标,SNRS提示激素抵抗。
研究设计与样本
- 回顾性队列研究,纳入858例IgA肾病患者,采用Kaplan-Meier和Cox回归分析评估激素治疗对长期预后的影响,并根据MEST-C评分确定SRS和SNRS。
主要发现
- 匹配后激素治疗组与未治疗组20年肾脏生存率分别为75.5% vs 61.7%(P=0.025),eGFR分别为79.4 vs 77.0 ml/min per 1.73 m2(无显著差异),蛋白尿分别为0.80 vs 0.62 g/d(无显著差异)。
- 激素治疗改善M1、E1、S1、C1+2和T0评分患者的肾脏生存率。
- 多变量Cox回归分析显示,激素治疗改善高SRS且任意SNRS患者的肾脏预后,而对中SRS且任意SNRS患者无此效果。
关键数值与推荐
- SRS为M1、E1、S1和C1+2评分之和(0分:低,1-2分:中,3-4分:高)。
- SNRS为T1+2评分之和(0分:低,1分:高)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The usefulness of the Oxford classification (MEST-C score) for deciding the management approach for IgA nephropathy (IgAN) remains unclear. METHODS: Effects of steroid therapy on the long-term prognosis for all 858 patients with IgAN and patients classified according to each MEST-C score were evaluated using Kaplan-Meier and Cox regression analyses. Steroid responder score (SRS) and steroid nonresponder score (SNRS) were determined using individual pathology scores when steroids were found to be independently associated, or not, with clinical benefits. In addition, the effects of steroid therapy according to the total SRS/SNRS were analyzed. RESULTS: Steroid therapy improved the 20-year renal survival rates of patients with IgAN after matching (steroids[+] vs. steroids[-]; estimated glomerular filtration rate [eGFR] [ml/min per 1.73 m2]: 79.4 vs. 77.0, not significant; proteinuria [g/d]: 0.80 vs. 0.62, not significant; renal survival rate: 75.5% vs. 61.7%; P = 0.025) and of patients with M1, E1, S1, C1+2, and T0 scores. Therefore, we considered the total of the M1, E1, S1, and C1+2 scores (point 0: low, 1-2: medium, and 3-4: high) as the SRS and the total of the T1+2 scores (0: low and 1: high) as the SNRS. Multivariate Cox regression analyses revealed that steroid therapy improved the renal prognosis of patients with IgAN with high SRS and any SNRS, unlike patients with IgAN with medium SRS and any SNRS. CONCLUSION: Patients with M1, E1, S1, and C1+2 scores responded to steroid therapy; however, those with T1+2 scores did not. Although a high SRS was a useful indicator for steroid therapy, SNRS indicated resistance to steroid therapy.
引用
- Itami S, Moriyama T, Miyabe Y, et al. A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy. Kidney Int Rep. 2021. PMID: 35005318. doi:10.1016/j.ekir.2021.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。